These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 32649312)
1. Association of the serum microRNA-29 family with cognitive impairment in Parkinson's disease. Han L; Tang Y; Bai X; Liang X; Fan Y; Shen Y; Huang F; Wang J Aging (Albany NY); 2020 Jul; 12(13):13518-13528. PubMed ID: 32649312 [TBL] [Abstract][Full Text] [Related]
2. Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease. Liang K; Li X; Guo Q; Ma J; Yang H; Fan Y; Yang D; Shi X; She Z; Qi X; Gu Q; Chen S; Zheng J; Li D Neurobiol Dis; 2024 Jan; 190():106379. PubMed ID: 38104911 [TBL] [Abstract][Full Text] [Related]
3. Cognitive Function and Quality of Life in Parkinson's Disease: A Cross-Sectional Study. Tang Y; Liang X; Han L; Peng F; Shen B; Yu H; Shen Y; Shen C; Yu J; Wang J J Parkinsons Dis; 2020; 10(3):1209-1216. PubMed ID: 32568115 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of blood serum microRNA 29 family in patients with Parkinson's disease. Bai X; Tang Y; Yu M; Wu L; Liu F; Ni J; Wang Z; Wang J; Fei J; Wang W; Huang F; Wang J Sci Rep; 2017 Jul; 7(1):5411. PubMed ID: 28710399 [TBL] [Abstract][Full Text] [Related]
5. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort. Hobson P; Meara J Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160 [TBL] [Abstract][Full Text] [Related]
6. Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease. van der Zee S; Vermeiren Y; Fransen E; Van Dam D; Aerts T; Gerritsen MJ; Spikman JM; van Laar T; De Deyn PP J Parkinsons Dis; 2018; 8(1):71-84. PubMed ID: 29480224 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog. Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719 [TBL] [Abstract][Full Text] [Related]
8. Plasma miR-203a-3p as a Novel Predictor of Dementia in Patients with Parkinson's Disease. Hsu YF; Lin SP; Chu YT; Tsai YT; Huang JW; Phoa FKH; Wu RM Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542526 [TBL] [Abstract][Full Text] [Related]
9. A time-efficient screening tool for activities of daily living functions in Parkinson's disease dementia. Sulzer P; Liebig L; Csoti I; Graessel E; Wurster I; Berg D; Liepelt-Scarfone I J Clin Exp Neuropsychol; 2020 Oct; 42(8):867-879. PubMed ID: 33043797 [TBL] [Abstract][Full Text] [Related]
10. Cognitive function in the early phase of Parkinson's disease, a five-year follow-up. Domellöf ME; Ekman U; Forsgren L; Elgh E Acta Neurol Scand; 2015 Aug; 132(2):79-88. PubMed ID: 25644230 [TBL] [Abstract][Full Text] [Related]
11. Domain specific cognitive impairment in Parkinson's patients with mild cognitive impairment. Chaudhary S; Kumaran SS; Kaloiya GS; Goyal V; Sagar R; Kalaivani M; Jaganathan NR; Mehta N; Srivastava A J Clin Neurosci; 2020 May; 75():99-105. PubMed ID: 32192853 [TBL] [Abstract][Full Text] [Related]
12. Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson's Disease in the ICICLE-PD Cohort. Lawson RA; Williams-Gray CH; Camacho M; Duncan GW; Khoo TK; Breen DP; Barker RA; Rochester L; Burn DJ; Yarnall AJ; J Parkinsons Dis; 2021; 11(3):1297-1308. PubMed ID: 34024781 [TBL] [Abstract][Full Text] [Related]
13. Education-corrected CERAD identifies MCI and dementia in Parkinson's disease. Karrasch M; Laatu S; Ellfolk U; Marttila R; Martikainen K Acta Neurol Scand; 2015 Apr; 131(4):219-24. PubMed ID: 25273524 [TBL] [Abstract][Full Text] [Related]
14. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition. Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230 [TBL] [Abstract][Full Text] [Related]
15. A task-specific cognitive domain decline is correlated with plasma and neuroimaging markers in patients with Parkinson's disease. Li CH; Chen TF; Peng PL; Lin CH J Neurol; 2022 Dec; 269(12):6530-6543. PubMed ID: 35965282 [TBL] [Abstract][Full Text] [Related]
16. Fist-Edge-Palm (FEP) test has a high sensitivity in differentiating dementia from normal cognition in Parkinson's disease. Liu Y; Qiu MY; Zhang YL; Zhang XJ; Truong D; Tan EK; Wu YC J Neurol Sci; 2021 Oct; 429():118060. PubMed ID: 34479167 [TBL] [Abstract][Full Text] [Related]
17. Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia. Biundo R; Weis L; Facchini S; Formento-Dojot P; Vallelunga A; Pilleri M; Antonini A Parkinsonism Relat Disord; 2014 Apr; 20(4):394-9. PubMed ID: 24495708 [TBL] [Abstract][Full Text] [Related]
18. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment. Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006 [TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome contributes to cognitive impairment in patients with Parkinson's disease. Peng Z; Dong S; Tao Y; Huo Y; Zhou Z; Huang W; Qu H; Liu J; Chen Y; Xu Z; Wang Y; Zhou H Parkinsonism Relat Disord; 2018 Oct; 55():68-74. PubMed ID: 29908727 [TBL] [Abstract][Full Text] [Related]
20. Cortical excitability changes as a marker of cognitive impairment in Parkinson's disease. Kamble N; Bhattacharya A; Hegde S; Vidya N; Gothwal M; Yadav R; Pal PK Behav Brain Res; 2022 Mar; 422():113733. PubMed ID: 34998797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]